We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.98B
AUM Growth
+$132M
Cap. Flow
+$20.2M
Cap. Flow %
0.34%
Top 10 Hldgs %
41.51%
Holding
666
New
23
Increased
324
Reduced
223
Closed
42

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$142M
2
ASML icon
ASML
ASML
+$117M
3
TSEM icon
Tower Semiconductor
TSEM
+$112M
4
LRCX icon
Lam Research
LRCX
+$88M
5
MU icon
Micron Technology
MU
+$53.9M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$81.3M
2
LITE icon
Lumentum
LITE
+$72.3M
3
PM icon
Philip Morris
PM
+$40M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
META icon
Meta Platforms (Facebook)
META
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 54.47%
2 Communication Services 12.44%
3 Consumer Discretionary 11.77%
4 Consumer Staples 6.03%
5 Healthcare 5.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
251
AT&T
T
$155B
$312K 0.01%
10,768
-2,897
-21% -$77.4K
MEDP icon
252
Medpace
MEDP
$15.2B
$303K 0.01%
632
+80
+14% +$41K
HIMS icon
253
Hims & Hers Health
HIMS
$7.58B
$298K 0.01%
14,343
-15,051
-51% -$356K
NBIX icon
254
Neurocrine Biosciences
NBIX
$18B
$295K ﹤0.01%
2,240
+282
+14% +$37.4K
MOH icon
255
Molina Healthcare
MOH
$11.8B
$288K ﹤0.01%
2,159
+800
+59% +$127K
SNY icon
256
Sanofi
SNY
$105B
$286K ﹤0.01%
5,943
+744
+14% +$34.7K
CVX icon
257
Chevron
CVX
$381B
$284K ﹤0.01%
+1,374
New +$251K
ACN icon
258
Accenture
ACN
$86.2B
$284K ﹤0.01%
1,432
+485
+51% +$113K
UHS icon
259
Universal Health Services
UHS
$9.08B
$275K ﹤0.01%
1,539
– –
IONS icon
260
Ionis Pharmaceuticals
IONS
$8.82B
$273K ﹤0.01%
3,637
+454
+14% +$35.8K
HD icon
261
Home Depot
HD
$331B
$270K ﹤0.01%
821
– –
GH icon
262
Guardant Health
GH
$20.2B
$268K ﹤0.01%
2,906
+365
+14% +$36.6K
IBM icon
263
IBM
IBM
$198B
$267K ﹤0.01%
1,103
– –
MDGL icon
264
Madrigal Pharmaceuticals
MDGL
$12.6B
$267K ﹤0.01%
510
+65
+15% +$31.1K
EXEL icon
265
Exelixis
EXEL
$14.1B
$258K ﹤0.01%
6,022
+754
+14% +$32.4K
JAZZ icon
266
Jazz Pharmaceuticals
JAZZ
$16B
$258K ﹤0.01%
1,364
+170
+14% +$29.7K
SOLV icon
267
Solventum
SOLV
$13.6B
$246K ﹤0.01%
3,768
– –
BMRN icon
268
BioMarin Pharmaceuticals
BMRN
$11.4B
$244K ﹤0.01%
4,315
+541
+14% +$31.5K
BKV
269
BKV Corp
BKV
$2.87B
$239K ﹤0.01%
8,370
+1,018
+14% +$29.5K
SUI icon
270
Sun Communities
SUI
$14.7B
$238K ﹤0.01%
1,893
-181
-9% -$23.4K
ESS icon
271
Essex Property Trust
ESS
$18.9B
$236K ﹤0.01%
974
-93
-9% -$23.5K
BAX icon
272
Baxter International
BAX
$11.5B
$233K ﹤0.01%
13,881
– –
KIM icon
273
Kimco Realty
KIM
$17.6B
$230K ﹤0.01%
10,235
-980
-9% -$21.6K
CRL icon
274
Charles River Laboratories
CRL
$10.6B
$229K ﹤0.01%
1,325
– –
EGY icon
275
Vaalco Energy
EGY
$582M
$226K ﹤0.01%
35,630
+4,330
+14% +$21.8K
9 10
11
12 13

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q1 2026 Portfolio in Review

As of Q1 2026, GF Fund Management held 666 positions worth $5.98B, up 2.3% from $5.85B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

GF Fund Management's Q1 2026 filing shows 23 new, 324 increased, 223 reduced and 42 closed positions. Its largest new stake was Coherent: 98,000 shares worth $23.3M. The largest sale was Sandisk, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 51% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • GF Fund Management's largest Q1 2026 buy was Coherent: 98,000 shares worth $23.3M.
  • GF Fund Management added most to Walmart Inc in Q1 2026, an estimated $142M increase.
  • GF Fund Management's biggest Q1 2026 reduction was Sandisk, cutting an estimated $81.3M.
  • GF Fund Management fully exited AstraZeneca in Q1 2026, selling an estimated $12.4M.
  • GF Fund Management's ten largest holdings make up 42% of its $5.98B portfolio in Q1 2026.
  • GF Fund Management opened 23 new positions and closed 42 in Q1 2026.
  • GF Fund Management's portfolio value rose 2.3% quarter-over-quarter to $5.98B.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.